Dr John Hales' Research Group
This group is focused on developing new analytical technologies that will support the manufacture of cutting-edge biopharmaceutical products.
We are currently developing a new virus-laser system for monitoring the upstream process in close-to-real-time, and we are demonstrating applications for our TRIFLE technology in downstream processes.
We want to use our technologies to solve the most-pressing challenges in biopharmaceutical manufacturing. To realise this vision, we work collaboratively with partners from industry and have spun-out a company from UCL, Roxijen.
